BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance-Reference-Cited by-同舟云学术

BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance

Published:2018-09 Issue:13 Volume:24 Page:3513-3527.e7
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Nacson Joseph,Krais John J.,Bernhardy Andrea J.,Clausen Emma,Feng Wanjuan,Wang Yifan,Nicolas Emmanuelle,Cai Kathy Q.,Tricarico Rossella,Hua Xiang,DiMarcantonio Daniela,Martinez Esteban,Zong Dali,Handorf Elizabeth A.,Bellacosa Alfonso,Testa Joseph R.,Nussenzweig Andre,Gupta Gaorav P.,Sykes Stephen M.,Johnson Neil

Funder

NIH

Department of Defense

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference60 articles.

1. Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance;Anantha;eLife,2017

2. The CST complex mediates end protection at double-strand breaks and promotes PARP inhibitor sensitivity in BRCA1-deficient cells;Barazas;Cell Rep.,2018

3. Regulation of single-strand annealing and its role in genome maintenance;Bhargava;Trends Genet.,2016

4. 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers;Bouwman;Nat. Struct. Mol. Biol.,2010

5. Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer;Bowman-Colin;Proc. Natl. Acad. Sci. USA,2013

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shieldin and CST co-orchestrate DNA polymerase-dependent tailed-end joining reactions independently of 53BP1-governed repair pathway choice;Nature Structural & Molecular Biology;2024-09-03

2. PARPi, BRCA, and gaps: controversies and future research;Trends in Cancer;2024-09

3. Nucleolytic processing of abasic sites underlies PARP inhibitor hypersensitivity in ALC1-deficient BRCA mutant cancer cells;Nature Communications;2024-07-27

4. H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours;Nature Communications;2024-05-24

5. Discovery of a small-molecule inhibitor that traps Polθ on DNA and synergizes with PARP inhibitors;Nature Communications;2024-04-05